BioNeMo Agent Toolkit
NVIDIA Open-Source Toolkit Transforms LLMs into Molecular Biology AI Scientist Agents
The BioNeMo Agent Toolkit, announced by NVIDIA on June 23, 2026, is a next-generation open-source development toolkit designed to transform general-purpose large language models (LLMs) into AI scientist agents capable of autonomously performing specialized molecular biology research, such as drug discovery, protein structure prediction, and genome analysis. This toolkit provides an advanced orchestration framework that comprehensively connects NVIDIA's Nemotron, NemoClaw, and OpenShell technologies, as well as molecular biology-specific NIM microservices. Developers and researchers can use this to build autonomous agents that go beyond simple text responses or coding assistance, enabling them to deeply infer biological and chemical data, validate hypotheses, and autonomously establish optimal subsequent analysis steps. Traditional bio-computing and bioinformatics analysis methods have had clear limitations, requiring researchers to manually parse and link the individual inputs and outputs of various independent tools (e.g., AlphaFold, AutoDock, genome alignment tools). This is similar to a translator manually assembling each sentence by comparing a dictionary and grammar book, which has significantly hindered research efficiency. The BioNeMo Agent Toolkit completely intelligentizes and automates these fragmented workflows. In particular, by introducing a model context protocol server architecture, it enables AI agents to dynamically select and invoke various specialized "skills" based on the situation, allowing them to perform complex calculations such as protein structure analysis, molecular binding simulations, and gene analysis. Biotechnology researchers can use this toolkit to dramatically simplify the virtual screening process of small-molecule compounds for target proteins. For example, if the agent is provided with information about a target protein, it will automatically use the `boltz2-nim` skill to predict the 3D structure of the protein and then identify the active site. It then invokes a docking tool to simulate binding affinity, automatically deriving the top group of candidate compounds from a library of candidate compounds, and visualizes the analysis results in the form of a well-organized academic report. This process, which used to take weeks to analyze manually, can now be performed in just a few hours, dramatically shortening the speed of candidate compound selection before entering actual wet-lab experiments.
๐ป System Requirements
NVIDIA GPU with 8GB+ recommended (for local inference and running the API integration framework). When running NIM microservices in the cloud, the VRAM requirement is minimized to the level of API calls.
5GB or more for the entire package and agent workspace (may increase when downloading additional models locally).
โก Installation
### 4-1. Quick Start
```bash
pip install nvidia-nat
```
### 4-2. Detailed Installation
```bash
# 1. Clone and navigate to the NeMo Agent Toolkit repository
git clone -b main https://github.com/NVIDIA/NeMo-Agent-Toolkit.git
cd nemo-agent-toolkit
# 2. Synchronize submodules and enable Git LFS
git submodule update --init --recursive
git lfs install && git lfs fetch && git lfs pull
# 3. Create a virtual environment using uv and synchronize dependencies
uv venv --python 3.12 .venv
source .venv/bin/activate
uv sync --all-groups --all-extras
```๐งฌ Bio Use Cases
Virtual Screening of Small Molecule Compounds Targeting Proteins
Provide the FASTA sequence of the target protein and a compound library as input, and submit the 'Identify Compounds with Optimized Binding' prompt. The agent calls the `boltz2-nim` skill to predict the 3D structure and uses the `diffdock-nim` skill to perform docking simulations of 1,000 candidate compounds, selecting and recommending the top 5 candidates within 5 minutes.
De Novo Design of Protein Binders
Request the design of a protein that will deactivate the receptor of a specific target gene. The agent uses the `complexa-design` and `esmfold-nim` skills in conjunction to design three candidate protein binding structures with a large interaction area and low binding energy, and outputs the atomic coordinates (PDB) file to guide wet-lab experiments.
Automated Analysis of Genome Variation-Based Personalized Biomarkers
Input the variant data (VCF) of a patient's genome and instruct 'Analyze Clinical Treatment Potential'. The agent identifies variant locations and autonomously calls the NCBI and ClinVar API integration skills to extract pathogenic variants and related target genes, and maps them to clinical trial databases to propose two promising personalized drug candidates within 30 seconds.
๐ Update Notes
No update notes yet.
๐งช Related Code of Life
No related Code of Life posts yet.